Finzati - Logo
GMED logo

Globus Medical, Inc.

GMED • Medical - Devices
$78.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHLY FAVORABLE PROFILEExcellentConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$10.78B
Growth
13.5%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 18.3%Positive revenue growth · 23.0%Positive free cash flow · 4.36Consistent free cash flow · 5/5Reasonable earnings multiple · 21.94
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$78.00
Change0.00%
Shares Out138.19M
Market Cap$10.78B
Enterprise Value$10.29B
52W Range51.79 - 101.40
Beta0.95
P/E20.13
P/S3.43
P/B2.26
P/FCF11.74
EV/Sales3.27

Investment DNA

How strong this company looks for long-term investors

85
out of 100
Business Quality
Margins, moat, returns
83/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
70/100
Why this score▼
Stable or improving margins · 18.3%Positive revenue growth · 23.0%Positive free cash flow · 4.36Consistent free cash flow · 5/5Reasonable earnings multiple · 21.94Manageable debt level · 0.03

Analyst view

Analyst sentiment and price target

GMED
Analyst sentiment
Based on 36 analyst votes · 2026-09-04
85/100
Bullish
Bullish
26
Hold
9
Bearish
1
Price Target
2026-08-07
Low
$80.00
Mean
$98.88
Median
$100.00
High
$117.00

Company Overview

IPO: 8/3/2012
Industry: Medical - Devices
P/B i: 2.26
Debt / Equity i: 0.03
Operating Margin: 16.33%
Net Margin: 18.30%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.03
Current Ratio: 4.26
Quick Ratio: 2.74
Status: Good

Insider Transactions

Recent executive and insider activity

Davidar David D
Transaction: 07/27/2026
SELL
Change
-2,500
Price
Not reported
Filing
07/28/2026
Type
SELL
Davidar David D
Transaction: 06/05/2026
SELL
Change
-25,000
Price
$26.27
Filing
06/09/2026
Type
SELL
Davidar David D
Transaction: 06/05/2026
SELL
Change
-25,000
Price
$80.76
Filing
06/09/2026
Type
SELL